(aka resistance to structural change)
NOTE: This classification applies to specific transformational depths (from seed boundaries). SOS Classifications cannot be compared across different depths.
So a “resilient structure” classification for astronomical bodies cannot be compared to one for human immunity series.
This isnât a cell or a living thing. Itâs a process the body uses to decide which pieces of itself it will show to the immune system. Certain enzymes (like ERAP1) trim small proteins before they are placed on display by MHC I. This helps T cells learn what âselfâ looks like. But this editing only works under very specific conditions. Itâs easy to mess up, it doesnât last on its own, and it only exists to help other parts. That makes it a tool with a very fragile balance.
This system works inside normal cells â especially in the endoplasmic reticulum, a place where proteins are processed.
In this space:
It happens quietly, but the results shape what the immune system sees as normal.
The system includes:
It protects the body by making sure only safe, normal peptides are shown to T cells. This reduces the risk of the immune system attacking itself.
What makes it real:
Â
How itâs different:
Unlike other systems that destroy proteins completely, this one just tweaks the edges. Unlike systems that kill cells, this one helps them stay hidden when appropriate.
NA
NA
1. MHC I Molecules
The final display platform that receives trimmed peptides. Without correctly sized peptides, MHC I cannot complete its folding or presentation role.
2. Cytosolic Proteasome Complexes
These generate the initial pool of peptides from self-proteins. Their output provides the starting material that the editing system must refine.
3. TAP Transporters
These gate peptide entry into the endoplasmic reticulum. Editing can only occur on peptides that arrive through this transport step.
4. CD8âș T Cells
Though not in direct contact, these cells depend on the accuracy of edited peptideâMHC I displays to calibrate self-recognition and avoid autoimmune attack.
5. Inflammatory Signaling Layers (e.g., IFN-Îł)
These can modulate the activity of ERAP enzymes and TAP transport, indirectly altering what gets edited and shown.
1. Peptide Size Filtering
ERAP enzymes trim peptide ends to ensure they fit the narrow groove of MHC I. Peptides that are too long or short are discarded or fail to bind properly.
2. Temporal Sequencing
Peptides must be trimmed before MHC I binding occurs. If editing lags or is incomplete, the peptide will not be loaded or may lead to display failure.
3. Surface Shaping of Immune Visibility
The final peptideâMHC I complex is what CD8âș T cells scan. The editing system indirectly determines what the immune system sees as âself.â
4. Editing Collapse Under Stress
During high inflammation, ERAP activity may become dysregulated, leading to either over-trimming (loss of important self-peptides) or under-trimming (display of abnormal fragments).
5. Bypass Mechanisms in Tumors or Infections
Some pathogens or cancer cells deliberately downregulate ERAP or TAP to disrupt peptide editing and avoid immune detection.